Literature DB >> 12855264

Prognostic information in soft tissue sarcoma using tumour size, vascular invasion and microscopic tumour necrosis-the SIN-system.

P Gustafson1, M Akerman, T A Alvegård, J-M Coindre, C D M Fletcher, A Rydholm, H Willén.   

Abstract

We have earlier devised a system for soft tissue sarcoma (STS), based on three negative prognostic features: large tumour size, vascular invasion, and microscopic tumour necrosis, the SIN-system. Tumours which exhibit 2 or 3 of these features are categorised as high-risk, the others as low-risk. We have now tested this system for reproducibility both as regards recognition of its components, and as regards prognostic strength in patients from another institution. We have also compared it with the American Joint Committee on Cancer (AJCC) system. 200 patients with STS were analysed, all had been treated by surgery, in 97 patients combined with radiotherapy. The median follow-up for the 117 survivors was 10 (1.5-27) years. Without knowledge of the clinical data, three groups of pathologists independently reviewed original slides from all of the tumours. Based on the factors, the tumours were classified as high-risk or low-risk. The prognostic strength was compared using the results obtained by the different observers. Concordance in recognition of vascular invasion, tumour necrosis, and overall grading was seen in 156 (78%), 154 (77%), and 167 (84%) of the 200 tumours, respectively. Based on the different observers' grading, the cumulative 5-year metastasis-free survival rate (MFSR) varied for patients with low-risk tumours between 0.85 and 0.80, and for patients with high-risk tumours between 0.48 and 0.43. The Kappa-value for grading between all three groups of observers was 0.77. The SIN-system gave more clinically useful prognostic information than the AJCC system. Useful prognostic information in STS can be obtained by using tumour size, vascular invasion and microscopic tumour necrosis. This system provides two distinct prognostic groups, and has a high reproducibility.

Entities:  

Mesh:

Year:  2003        PMID: 12855264     DOI: 10.1016/s0959-8049(03)00369-1

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  21 in total

1.  [Diagnostic imaging and visualization of radiation treatment effects in soft tissue sarcomas].

Authors:  F Berger; M F Reiser; A Graser
Journal:  Radiologe       Date:  2012-03       Impact factor: 0.635

Review 2.  Magnetic resonance imaging of soft tissue sarcoma: features related to prognosis.

Authors:  Giulia Scalas; Anna Parmeggiani; Claudia Martella; Gianmarco Tuzzato; Giuseppe Bianchi; Giancarlo Facchini; Roberta Clinca; Paolo Spinnato
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-05-29

3.  [Soft tissue sarcoma of the upper extremities. Analysis of factors relevant for prognosis in 160 patients].

Authors:  M Lehnhardt; C Hirche; A Daigeler; O Goertz; A Ring; T Hirsch; D Drücke; J Hauser; H U Steinau
Journal:  Chirurg       Date:  2012-02       Impact factor: 0.955

Review 4.  [Malignant fibrous histiocytoma in the parotid gland. Case series and literature review].

Authors:  F Sachse; C August; J Alberty
Journal:  HNO       Date:  2006-02       Impact factor: 1.284

Review 5.  [Imaging of soft tissue sarcomas: standard approaches and new strategies].

Authors:  F Berger; E C Winkler; C Ruderer; M F Reiser
Journal:  Chirurg       Date:  2009-03       Impact factor: 0.955

6.  [Soft tissue sarcoma].

Authors:  P-U Tunn; B Gebauer; J Fritzmann; M Hünerbein; P M Schlag
Journal:  Chirurg       Date:  2004-12       Impact factor: 0.955

7.  Expression profiling using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic value of Ki-67.

Authors:  Jacob Engellau; Annette Persson; Pär-Ola Bendahl; Måns Akerman; Henryk A Domanski; Bodil Bjerkehagen; Peer Lilleng; Johan Weide; Anders Rydholm; Thor A Alvegård; Mef Nilbert
Journal:  Virchows Arch       Date:  2004-08-07       Impact factor: 4.064

8.  The Prognostic Value of Lymphovascular Invasion in Truncal and Extremity Soft Tissue Sarcomas: An Analysis from the National Cancer Database.

Authors:  Cecilia G Ethun; Alexandra G Lopez-Aguiar; Jeffery M Switchenko; Theresa W Gillespie; Keith A Delman; Charles A Staley; Shishir K Maithel; Kenneth Cardona
Journal:  Ann Surg Oncol       Date:  2019-09-09       Impact factor: 5.344

9.  Prognostic value of 18F-FDG PET/CT in patients with soft tissue sarcoma: comparisons between metabolic parameters.

Authors:  Sun-pyo Hong; Seung Eun Lee; Yoon-La Choi; Sung Wook Seo; Ki-Sun Sung; Hong Hoe Koo; Joon Young Choi
Journal:  Skeletal Radiol       Date:  2014-02-15       Impact factor: 2.199

Review 10.  [Surgical treatment of musculoskeletal soft tissue sarcomas].

Authors:  M Rudert; R Burgkart; R Gradinger; H Rechl
Journal:  Chirurg       Date:  2009-03       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.